Alberta Investment Management Corp - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 355 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2013. The put-call ratio across all filers is 0.61 and the average weighting 1.1%.

Quarter-by-quarter ownership
Alberta Investment Management Corp ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$15,572,000
+51.4%
508,900
+1.5%
0.13%
+38.5%
Q1 2018$10,284,000
+1179.1%
501,400
+1533.2%
0.10%
+1271.4%
Q4 2017$804,000
+101.0%
30,700
+12.9%
0.01%
+133.3%
Q1 2017$400,000
-26.9%
27,200
-3.2%
0.00%
-40.0%
Q4 2016$547,000
-78.2%
28,100
-64.0%
0.01%
-80.0%
Q3 2016$2,511,000
-40.6%
78,016
-51.9%
0.02%
-47.9%
Q2 2016$4,226,000
-85.6%
162,216
-81.2%
0.05%
-87.6%
Q1 2016$29,395,000
-75.8%
863,3000.0%0.39%
-72.7%
Q4 2015$121,345,000
-47.9%
863,300
-13.0%
1.41%
-47.6%
Q3 2015$232,748,000
-12.8%
992,678
+1.2%
2.70%
-5.7%
Q2 2015$266,797,000
+26.4%
980,878
+13.6%
2.86%
+29.7%
Q1 2015$211,130,000
+79.1%
863,478
+18.6%
2.21%
+76.6%
Q4 2014$117,888,000
+25.4%
728,178
+10.8%
1.25%
+26.9%
Q3 2014$93,992,000
-14.6%
657,178
-20.3%
0.98%
-17.7%
Q2 2014$110,042,000
+29.5%
824,678
+38.3%
1.20%
+17.6%
Q1 2014$85,002,000
-1.8%
596,378
-15.3%
1.02%
-7.5%
Q4 2013$86,534,000
+37.7%
704,278
+20.1%
1.10%
+33.8%
Q3 2013$62,831,000
+77.6%
586,378
+50.2%
0.82%
-4.8%
Q2 2013$35,381,000390,2780.86%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q2 2013
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,373,210$47,796,00039.06%
Claren Road Asset Management, LLC 77,527$1,561,00018.46%
Okumus Fund Management Ltd. 4,242,012$85,434,00014.79%
Chou Associates Management 1,446,843$29,139,00011.12%
FARLEY CAPITAL L.P. 307,458$6,192,0009.65%
HAP Trading, LLC 3,129,700$112,397,0006.58%
Pershing Square Capital Management 21,591,122$434,845,0005.79%
NORTH TIDE CAPITAL, LLC 2,500,000$50,350,0005.61%
Convector Capital Management, LP 192,000$3,867,0005.34%
Nebula Capital Management, LP 31,770$640,0005.07%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders